# IMMUNOMEDICS INC

IMMUNOMEDICS INC is a company headquartered in Morris Plains, NJ, United States.

## Company overview

- **Legal name:** IMMUNOMEDICS INC
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Morris Plains, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000722830

## About

IMMUNOMEDICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000722830, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2020-02-27, it reported annual revenue of USD 295,000; net income of USD -357,190,000; total assets of USD 671,722,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $295,000 (USD 295,000)
- **Net income:** -$357.2M (USD -357,190,000)
- **Total assets:** $671.7M (USD 671,722,000)
- **Cash and equivalents:** $608.6M (USD 608,628,000)
- **Operating cash flow:** -$222.4M (USD -222,442,000)

### FY2018 (period ended 2018-06-30)

- **Revenue:** $2.2M (USD 2,155,996)
- **Net income:** -$273.8M (USD -273,836,887)
- **Total assets:** $664.2M (USD 664,173,249)
- **Cash and equivalents:** $612.1M (USD 612,056,502)
- **Operating cash flow:** -$134.0M (USD -133,950,886)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2017 (period ended 2017-06-30)

- **Revenue:** $3.1M (USD 3,091,250)
- **Net income:** -$153.2M (USD -153,205,945)
- **Total assets:** $162.6M (USD 162,573,392)
- **Cash and equivalents:** $43.4M (USD 43,393,570)
- **Operating cash flow:** -$62.3M (USD -62,250,144)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-06-30)

- **Revenue:** $3.2M (USD 3,233,247)
- **Net income:** -$59.0M (USD -59,036,950)
- **Total assets:** $57.0M (USD 56,950,268)
- **Cash and equivalents:** $13.2M (USD 13,203,625)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-10-23 — period 2020-10-23 — FORM 8-K
- Form 8-K — filed 2020-09-21 — period 2020-09-19 — FORM 8-K
- Form 8-K — filed 2020-09-17 — period 2020-09-12 — FORM 8-K
- Form 8-K — filed 2020-09-14 — period 2020-09-13 — FORM 8-K
- Form 8-K — filed 2020-08-17 — period 2020-08-14 — FORM 8-K
- Form 8-K — filed 2020-08-05 — period 2020-08-05 — FORM 8-K
- Form 10-Q — filed 2020-08-05 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-07-06 — period 2020-07-06 — FORM 8-K
- Form 8-K — filed 2020-06-18 — period 2020-06-18 — FORM 8-K
- Form 8-K — filed 2020-05-27 — period 2020-05-27 — FORM 8-K
- Form 8-K — filed 2020-05-07 — period 2020-05-05 — FORM 8-K
- Form 10-Q — filed 2020-05-06 — period 2020-03-31 — 10-Q

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/immunomedics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology